Multisystem inflammatory syndrome in children following COVID-19

Researchers from the Mount Sinai Health System, NY, present the first genome-wide study to investigate the cause of a rare but severe inflammatory syndrome in children following SARS-CoV-2 infection. RNA sequencing of blood samples revealed that certain cells of the immune system were at lower levels in children who developed multisystem inflammatory syndrome after SARS-CoV-2 infection. The findings may provide scientists with a new pathway toward the treatment of multisystem inflammatory syndrome in children (MIS-C).